April kept the momentum going.
After a strong start to 2026, healthtech funding continues to show where conviction is building and where it’s quietly shifting.
From large-scale clinical AI platforms and medtech intelligence layers to next-gen therapeutics and revenue cycle infrastructure, capital is flowing into companies that are moving beyond experimentation and into real-world deployment.
What stands out this month isn’t just the size of the rounds, but the maturity of the bets. Investors are backing platforms that plug directly into care delivery, improve clinical decision-making, or unlock operational efficiency at scale.
Here’s a look who raised what:
1. Aidoc
Funds raised: $150 million
Funding round: Series E
Investors: Growth Equity at Goldman Sachs Alternatives (lead), General Catalyst, SoftBank Investment Advisors, NVentures (NVIDIA’s venture arm)
About: Aidoc is a clinical AI company focused on medical imaging and care coordination. Its platform uses AI (including its CARE™ foundation model) to analyze CT scans and other imaging data, helping clinicians detect conditions earlier, prioritize urgent cases, and improve diagnostic accuracy.
How it plans to use the funds:
- Expand and advance its CARE™ clinical foundation model
- Scale its enterprise AI platform (aiOS™) globally
- Broaden clinical use cases
- Develop automated imaging reporting
2. Chapter
Funds raised: $100 million
Funding round: Series E
Investors: Generation Investment Management (lead), Fifth Down Capital, 8VC, Stripes, XYZ Venture Capital, Addition, Narya Capital, Susa Ventures, Maverick Ventures
About: Chapter is a Medicare navigation platform helping seniors choose and optimize health coverage using a mix of licensed advisors and data-driven tools.
How it plans to use the funds:
- Expand advisor network
- Invest in tech and data capabilities
- Scale nationwide
- Improve Medicare optimization platform
3. AcuityMD
Funds raised: $80 million
Funding round: Series C
Investors: StepStone Group (lead), Benchmark, Redpoint Ventures, ICONIQ, Atreides Management
About: AcuityMD is a medtech intelligence platform using AI and healthcare data to help medical device companies improve commercialization strategies.
How it plans to use the funds:
- Enhance AI capabilities
- Expand proprietary data
- Broaden platform use cases
- Scale product and growth
4. STORM Therapeutics
Funds raised: $56 million
Funding round: Series C
Investors: M Ventures, Pfizer Ventures, Taiho Ventures, IP Group, UTokyo IPC, Fast Track Initiative
About: STORM Therapeutics is a clinical-stage biotech developing RNA-modifying therapies for cancer, targeting RNA methylation pathways.
How it plans to use the funds:
- Advance STC-15 into Phase 2 trials
- Support regulatory pathway
- Expand oncology pipeline
5. Nervonik
Funds raised: $52.5 million
Funding round: Series B
Investors: Amzak Health (lead), Elevage Medical Technologies, USVP, Lumira Ventures, Foothill Ventures, Shangbay Capital
About: Nervonik develops next-gen peripheral nerve stimulation technologies with real-time sensing for chronic pain and neurological conditions.
How it plans to use the funds:
- Advance PNS system development
- Expand clinical trials
- Prepare for commercialization
6. Courier Health
Funds raised: $50 million
Funding round: Series B
Investors: Oak HC/FT (lead), Norwest, Work-Bench
About: Courier Health builds an AI-driven patient experience platform for life sciences, streamlining patient journeys from onboarding to adherence.
How it plans to use the funds:
- Expand product and AI capabilities
- Scale team and operations
- Grow biopharma adoption
7. Cala Health
Funds raised: $50 million
Funding round: Growth capital (debt financing)
Investors: Trinity Capital
About: Cala Health develops wearable neuromodulation therapies like Cala kIQ for essential tremor and Parkinson’s disease.
How it plans to use the funds:
- Expand commercialization
- Scale distribution
- Invest in product innovation
8. Tava Health
Funds raised: $40 million
Funding round: Series C
Investors: Centana Growth Partners (lead), Catalyst Investors, Blue Heron Ventures, Peterson Ventures, Springtide Ventures
About: Tava Health is a hybrid mental health platform offering virtual and in-person therapy matched via algorithms.
How it plans to use the funds:
- Expand platform and services
- Launch AI-enabled tools
- Strengthen ecosystem support
- Scale operations
9. SquareMind
Funds raised: $18 million
Funding round: Pre-Series A
Investors: Sonder Capital (lead), Deeptech 2030 Fund, Adamed Technology, Calm/Storm Ventures, Teampact Ventures
About: SquareMind develops AI-powered robotic dermatology solutions like Swan for full-body skin imaging.
How it plans to use the funds:
- Launch in US & Europe
- Expand teams
- Scale standardized skin exams
10. Joyful Health
Funds raised: $17 million
Funding round: Series A
Investors: CRV (lead), XYZ Venture Capital, Designer Fund, Inflect Capital, Go Global Ventures
About: Joyful Health builds AI financial infrastructure for healthcare revenue cycle management and claims recovery.
How it plans to use the funds:
- Expand team
- Accelerate product
- Scale platform
- Meet enterprise demand
11. Keebler Health
Funds raised: $16 million
Funding round: Series A
Investors: Flare Capital Partners (lead), Sands Capital, Tau Ventures, Freestyle Capital, Underdog Labs, MBX Capital
About: Keebler Health is an LLM-native risk adjustment platform processing unstructured clinical data to improve coding and reimbursement.
How it plans to use the funds:
- Expand AI platform
- Scale growth
- Build value-based care infrastructure
- Extend into compliance workflows
12. Almanac Health
Funds raised: $10 million
Funding round: Seed
Investors: F-Prime (lead), General Catalyst, Lightspeed Venture Partners
About: Almanac Health provides evidence-based clinical AI using RAG grounded in medical research for decision support.
How it plans to use the funds:
- Expand clinical & AI teams
- Advance R&D and validation
- Scale platform deployment
Wrapping up
If April tells us anything, it’s this: healthtech is getting sharper.
The scattershot experimentation phase is giving way to focused, infrastructure-level innovation. AI embedded into workflows, devices built for clinical precision, and platforms designed to scale across systems, not just pilots.
We’re also seeing a clear pattern:
- Bigger rounds going to companies with proven traction
- Continued appetite for AI-native healthcare platforms
- And sustained investment across both digital health and biotech
In short, capital is following impact, integration, and outcomes.
Source: HealthTech Alpha’s funding data
We’re the exclusive HealthTech Alpha partners in India! Reach out if you’re looking for deeper market intelligence or strategic perspectives.
